Faculty

Vera Moiseenkova-Bell, PhD

faculty photo
Professor of Pharmacology
Department: Systems Pharmacology and Translational Therapeutics

Contact information
Department of Systems Pharmacology and Translational Therapeutics
University of Pennsylvania, Perelman School of Medicine
10-124 Smilow Center for Translational Research
3400 Civic Center Boulevard, Building 421
Philadelphia, PA 19104-5158
Office: 215 898-1154
Education:
MS (Laser Biophysics)
M.V. Lomonosov Moscow State University, 1999.
PhD (Cellular Physiology & Molecular Biophysics)
The University of Texas Medical Branch, 2004.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Swanson N. A., Lokareddy R. K., Li F., Hou C-F., Leptihn S., Pavlenok M., Neiderweis M., Pumroy R. A., Moiseenkova-Bell V. Y., Cingolani G. : Cryo-EM structure of the periplasmic tunnel of T7 DNA-ejectosome at 2.7 Å resolution. Molecular Cell July 2021.

Moiseenkova-Bell V.Y., Delemotte L., Minor Jr D.L: Ion channels: Intersection of Structure, Function, and Pharmacology. Journal of Molecular Biology June 2021.

Fluck E.C., Pumroy R.A., Moiseenkova-Bell V.Y. : Production and purification of TRPV2 and TRPV5 for structural and functional studies. Methods Enzymology May 2021.

3. Conde J., Pumroy R.A., Baker C., Rodrigues T., Guerreiro A., Sousa B., Marques M.C., de Almeida B.P., Lee S., Leites E., Picard D., Samanta A., Vaz S.H., Sieglitz F., Langini M., Remke M., Roque R., Weiss T., Weller M., Liu Y., Han S., Corzana F., Morais V., Faria C.C., Carvalho T., Filippakopoulos P., Snijder B., Barbosa-Morais N.L., Moiseenkova-Bell V.Y., Bernardes G.J.L. : Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression. ACS Central Science April 2021.

Zhao Y., McVeigh B., Moiseenkova-Bell V.Y. : Structural Pharmacology of TRP Channels. Journal of Molecular Biology March 2021.

Asangani I., Blair I.A., van Duyne G., Hilser V., Moiseenkova-Bell V.Y., Plymate S., Sprenger C., Wand J., Penning T.M. : Using biochemistry and biophysics to extinguish Androgen Receptor signaling in prostate cancer. Journal of Biological Chemistry January 2021.

Pumroy R.A., Fluck E.C., Ahmed T., Moiseenkova-Bell V.Y. : Structural insights into the gating mechanisms of TRPV channels. Cell Calcium 87: 102168, May 2020 Notes: doi: 10.1016/j.ceca.2020.102168. Epub 2020 Jan 24.

Xu Z., Wise M.C., Chokkalingam N., Walker S., Tello-Ruiz E., Elliott S., Perales-Puchalt A., Xiao P., Zhu X., Pumroy R.A., Fisher P.D., Schultheis K., Schade E., Menis S., Guzman S., Andersen H., Broderick K.E., Humeau L.M., Muthumani K., Moiseenkova-Bell V.Y., Schief W.R., Weiner D.B., Kulp D.W. : Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity. Advanced Science Feb 2020 Notes: doi.org/10.1002/advs.201902802.

Fricke T.C., Echtermeyer F., Zielke J., de la Roche J., Filipovic M.R., Claverol S., Herzog C., Tominaga M., Pumroy R.A., Moiseenkova-Bell V.Y., Zygmunt P., Leffler A., Eberhardt M.J. : Oxidation of methionine residues activates the high-threshold heat-sensitive ion channel TRPV2. PNAS 116(48): 24359-24365, Nov 2019 Notes: doi: 10.1073/pnas.1904332116. Epub 2019 Nov 12.

Hughes T.E.T., del Rosario J., Kapoor A., Yazici A.T., Fluck E.C., Filizola M., Rohacs T., Moiseenkova-Bell V.Y. : Structure-based discovery of novel TRPV5 inhibitors. eLife 8, Oct 2019 Notes: pii: e49572. doi: 10.7554/eLife.49572.

back to top
Last updated: 06/22/2021
The Trustees of the University of Pennsylvania